Stock-Based Compensation - AMEA 2020 Equity Incentive Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Shares Available for Grant
Beginning number of shares, available for grant (in shares)	5,438,296	5,231,624	1,819,223
Ending number of shares, available for grant (in shares)	12,003,394	5,438,296	5,231,624	1,819,223
Shares Subject to Options Outstanding
Beginning number of shares, outstanding (in shares)	3,402,574	2,624,974	3,101,181
Granted (in shares)	1,000,760	1,051,466	345,774
Exercised (in shares)	(51,124)	(228,311)	(693,074)
Canceled (in shares)	(339,307)	(60,683)	(128,907)
Ending number of shares, outstanding (in shares)	4,012,903	3,402,574	2,624,974	3,101,181
Weighted-Average Exercise Price
Beginning balance of options outstanding (in usd per share)	$ 34.34	$ 29.17	$ 15.80
Granted (in usd per share)	30.80	44.86	119.82
Exercised (in usd per share)	7.93	6.29	11.19
Canceled (in usd per share)	58.45	90.84	47.51
Ending balance of options outstanding (in usd per share)	$ 31.76	$ 34.34	$ 29.17	$ 15.80
Weighted-Average Remaining Contractual Life and Aggregate Intrinsic Value
Options outstanding, weighted average remaining contractual term (in years)	6 years 7 months 6 days	6 years 9 months 18 days	6 years 6 months	6 years 10 months 24 days
Options outstanding, aggregate intrinsic value	$ 39,115	$ 39,749	$ 193,014	$ 350,670
AMEA 2020 Plan | Common Class B
Shares Available for Grant
Beginning number of shares, available for grant (in shares)	0	340,928	542,220
Granted (in shares)			(826,667)
Canceled (in shares)		82,407	625,375
Canceled in connection with the Joint Venture Acquisition (in shares)		(423,335)
Ending number of shares, available for grant (in shares)		0	340,928	542,220
Shares Subject to Options Outstanding
Beginning number of shares, outstanding (in shares)	0	3,652,219	4,053,335
Granted (in shares)			826,667
Exercised (in shares)		(2,051,645)	(602,408)
Canceled (in shares)		(82,407)	(625,375)
Canceled in connection with the Joint Venture Acquisition (in shares)		(1,518,167)
Ending number of shares, outstanding (in shares)		0	3,652,219	4,053,335
Weighted-Average Exercise Price
Beginning balance of options outstanding (in usd per share)	$ 0	$ 0.58	$ 0.58
Granted (in usd per share)			0.58
Exercised (in usd per share)		0.58	0.58
Canceled (in usd per share)		0.58	0.58
Canceled in connection with the Joint Venture Acquisition (in usd per share)		0.58
Ending balance of options outstanding (in usd per share)		$ 0	$ 0.58	$ 0.58
Weighted-Average Remaining Contractual Life and Aggregate Intrinsic Value
Options outstanding, weighted average remaining contractual term (in years)		0 years	8 years 9 months 18 days	9 years 7 months 6 days
Options outstanding, aggregate intrinsic value		$ 0	$ 0	$ 0